SUBSCRIBE
SUBSCRIBE
News   Business

Pacific Biosciences Appoints Michael J. Glynn as Chief Commercial Officer

October 4, 2011 | 
1 min read
MENLO PARK, Calif.--(BUSINESS WIRE)--Pacific Biosciences of California, Inc. (NASDAQ: PACB), provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael J. Glynn as Chief Commercial Officer.
People
PacBio
MORE ON THIS TOPIC
business
Government
Makary’s reported FDA removal could be ‘broad positive’ for biopharma
May 11, 2026
 · 
3 min read
 · 
Tristan Manalac
FDA commissioner Marty Makary speaking on a Youtube video, wearing a dark suit and a blue tie
FDA
Trump signs off on plan to oust embattled FDA Commissioner Marty Makary: report
May 8, 2026
 · 
2 min read
 · 
Annalee Armstrong
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VI
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
May 8, 2026
 · 
1 min read
 · 
Gabrielle Masson
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Odyssey launches upsized $279M IPO, Seaport docks on Nasdaq
May 8, 2026
 · 
12 min read
 · 
Editorial Team